Brett Matthew Hall is CSO at Immuneering Corp (IMRX). They have made 7 open-market trades across 1 company since 2021, most recently 2026-06-15.
CIK 0001870437
7 open-market purchases totalling $129K since 2021, never a sale. Across 7 scored buys the stock is up 29.7% at ninety days, and 28.4 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| IMRX | 382,531 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2026-06-16 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 86% | 71% | 71% |
| Avg Move | +19.1% | +6.2% | +29.7% |
| Alpha | +18.6% | +7.3% | +28.4% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMRX | BUY | 2026-06-15 | 2026-06-16 | $4.15 | $25K | +19.5% | +13.3% | +3.0% |
| IMRX | BUY | 2026-01-15 | 2026-01-16 | $4.57 | $11K | +8.2% | +13.8% | +23.8% |
| IMRX | BUY | 2025-06-20 | 2025-06-24 | $2.58 | $35K | +40.6% | +38.9% | +203.1% |
| IMRX | BUY | 2024-03-20 | 2024-03-21 | $2.86 | $20K | -5.9% | -32.5% | -44.7% |
| IMRX | BUY | 2022-05-25 | 2022-05-27 | $3.92 | $10K | +40.4% | +11.4% | +37.6% |
| IMRX | BUY | 2022-03-23 | 2022-03-23 | $7.91 | $8K | +0.5% | -24.2% | -40.4% |
| IMRX | BUY | 2021-08-03 | 2021-08-04 | $15.00 | $20K | +30.0% | +22.9% | +25.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.